A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis

Neurocysticercosis is a major cause of seizures worldwide. This double-blind trial of a 10-day course of albendazole included 30 months of follow-up. With the antiparasitic treatment there was some reduction in the number of partial seizures and a significant reduction in the number of seizures with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2004-01, Vol.350 (3), p.249-258
Hauptverfasser:	Garcia, Héctor H, Pretell, E. Javier, Gilman, Robert H, Martinez, S. Manuel, Moulton, Lawrence H, Del Brutto, Oscar H, Herrera, Genaro, Evans, Carlton A.W, Gonzalez, Armando E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Albendazole - adverse effects Albendazole - therapeutic use Anti-Inflammatory Agents - therapeutic use Anticestodal Agents - adverse effects Anticestodal Agents - therapeutic use Anticonvulsants - therapeutic use Biological and medical sciences Brain Brain - pathology Brain Diseases - complications Brain Diseases - drug therapy Brain Diseases - pathology Clinical trials Convulsions & seizures Cysticercosis Dexamethasone - therapeutic use Diseases caused by cestodes Double-Blind Method Drug Therapy, Combination Female Follow-Up Studies Granuloma - etiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Helminthic diseases Humans Infectious diseases Magnetic Resonance Imaging Male Medical disorders Medical sciences Medical treatment Middle Aged Nervous system (semeiology, syndromes) Neurocysticercosis - complications Neurocysticercosis - drug therapy Neurocysticercosis - pathology Neurology Parasitic diseases Seizures - drug therapy Seizures - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!